Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial. [electronic resource] by
- Cranston, Amy
- Stocken, Deborah D
- Stamp, Elaine
- Roblin, David
- Hamlin, Julia
- Langtry, James
- Plummer, Ruth
- Ashworth, Alan
- Burn, John
- Rajan, Neil
Producer: 20180320
In:
Trials vol. 18
Availability: No items available.
|
|
8.
|
|
|
9.
|
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. [electronic resource] by
- Vickers, Richard J
- Tillotson, Glenn S
- Nathan, Richard
- Hazan, Sabine
- Pullman, John
- Lucasti, Christopher
- Deck, Kenneth
- Yacyshyn, Bruce
- Maliakkal, Benedict
- Pesant, Yves
- Tejura, Bina
- Roblin, David
- Gerding, Dale N
- Wilcox, Mark H
Producer: 20170710
In:
The Lancet. Infectious diseases vol. 17
Availability: No items available.
|
|
10.
|
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial. [electronic resource] by
- Danilenko, Marina
- Stamp, Elaine
- Stocken, Deborah D
- Husain, Akhtar
- Zangarini, Monique
- Cranston, Amy
- Stones, Robert
- Sinclair, Naomi
- Hodgson, Kirsty
- Bowett, Susan A
- Roblin, David
- Traversa, Silvio
- Plummer, Ruth
- Veal, Gareth
- Langtry, James A A
- Ashworth, Alan
- Burn, John
- Rajan, Neil
Producer: 20190910
In:
JAMA dermatology vol. 154
Availability: No items available.
|